Device Trial Radar · NCT02520414
Symphion® System In-Office Study
Last checked: Nov 20, 2026Latest source record: Mar 26, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Minerva Surgical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 11, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and feasibility of using the Symphion system in an office setting.
Conditions
- Uterine Leiomyomas
- Endometrial Polyps
Interventions
Symphion® Bipolar Hysteroscopic Tissue Resection SystemDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety Profile of the Symphion® Bipolar Hysteroscopic Tissue Resection System When Used in the Office Setting for the Removal of Intracavitary Polyps and Myomas.Time frame: 2 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Center for Women's Surgery
Albuquerque, New Mexico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.